A fatal case of bowel obstruction caused by non-steroidal anti-inflammatory drug enteropathy

  • William Ryan HuddlestonEmail author
  • Christopher Johnson
Images in Forensics


We report the case of a 34-year-old woman who died after presenting to hospital with a 2-month history of vomiting, abdominal pain and diarrhea. Subsequent inquiries revealed that she had a history of non-steroidal anti-inflammatory drug (NSAID) abuse, and the autopsy revealed stricture formation consistent with being caused by NSAID enteropathy.


NSAID enteropathy Autopsy Bowel obstruction Strictures NSAID abuse 



We would like to thank David McCallum, Medical Illustration, Royal Victoria Hospital, Belfast for assistance with specimen photography, and Dr. James Lyness, State Pathologist, for assistance with photomicrographs.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Not applicable as the study subject was dead.


  1. 1.
    Lang J, Price AB, Levi AJ, Burke M, Gumpel JM, Bjarnason I. Diaphragm disease: pathology of disease of the small intestine induced by non-steroidal anti-inflammatory drugs. J Clin Pathol. 1988;41:516–26.CrossRefGoogle Scholar
  2. 2.
    Adebayo D, Bjarnason I. Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy? Postgrad Med J. 2006;82:186–91.CrossRefGoogle Scholar
  3. 3.
    Davies NM, Saleh JY, Skjodt NM. Detection and prevention of NSAID-induced enteropathy. Int J Pharm Pharm Sci. 2000;3:137–55.Google Scholar
  4. 4.
    Reuter BK, Davies NM, Wallace JL. Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation. Gastroenterology. 1997;112:109–17.CrossRefGoogle Scholar
  5. 5.
    Smale S, Tibble J, Sigthorsson G, Bjarnason I. Epidemiology and differential diagnosis of NSAID-induced injury to the mucosa of the small intestine. Best Pract Res Clin Gastroenterol. 2001;15:723–38.CrossRefGoogle Scholar
  6. 6.
    Bjarnason I, Hayllar J, MacPherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology. 1993;104:1832–47.CrossRefGoogle Scholar
  7. 7.
    Graham DY, Opekun AR, Willingham FF, Qureshi WA. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol. 2005;3:55–9.CrossRefGoogle Scholar
  8. 8.
    Meling TR, Aabakken L, Røseth A, Osnes M. Faecal calprotectin shedding after short-term treatment with non-steroidal anti-inflammatory drugs. Scand J Gastroenterol. 1996;31:339–44.CrossRefGoogle Scholar
  9. 9.
    Fortun PJ, Hawkey CJ. Nonsteriodal anti-inflammatory drugs and the small intestine. Curr Opin Gastroenterol. 2005;21:169–75.CrossRefGoogle Scholar
  10. 10.
    Wallace JL. Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy. World J Gastroenterol. 2013;19:1861–76.CrossRefGoogle Scholar
  11. 11.
    Mylonaki M, Fritscher-Ravens A, Swain P. Wireless capsule endoscopy: a comparison with push enteroscopy in patients with gastroscopy and colonoscopy negative gastrointestinal bleeding. Gut. 2003;52:1122–6.CrossRefGoogle Scholar
  12. 12.
    Rabenstein T, Krauss N, Hahn EG, Konturek P. Wireless capsule endoscopy - beyond the frontiers of flexible gastrointestinal endoscopy. Med Sci Monit. 2002;8:128–32.Google Scholar
  13. 13.
    Swain P. Wireless capsule endoscopy. Gut. 2003;52:48–50.CrossRefGoogle Scholar
  14. 14.
    Wallace JL. NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategies. Br J Pharmacol. 2012;165:67–74.CrossRefGoogle Scholar
  15. 15.
    Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S, Fort JG. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol. 2005;3:133–41.CrossRefGoogle Scholar
  16. 16.
    Hawkey CJ, Ell C, Simon B, Albert J, Keuchal M, McAlindon M, et al. Less small-bowel injury with lumiracoxib compared with naproxen plus omeprazole. Clin Gastroenterol Hepatol. 2008;6:536–44.CrossRefGoogle Scholar
  17. 17.
    Satoh H, Amagase K, Takeuchi K. Exacerbation of non-steroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility. J Pharmacol Exp Ther. 2012;343:270–7.CrossRefGoogle Scholar
  18. 18.
    Wallace JL, Syer S, Denou E, de Palma G, Vong L, McKnight W, et al. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology. 2011;141:1314–22.CrossRefGoogle Scholar
  19. 19.
    Park SC, Chun HJ, Kang CD, Sul D. Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury. World J Gastroenterol. 2011;17:4647–53.CrossRefGoogle Scholar
  20. 20.
    Bjarnason I, Zanelli G, Prouse P, Smethurst P, Smith T, Levi S, et al. Blood and protein loss via small intestinal inflammation induced by nonsteroidal anti-inflammatory drugs. Lancet. 1987;ii:711–4.CrossRefGoogle Scholar
  21. 21.
    Morris AJ, Madhok R, Sturrock RD, Capell HA, MacKenzie JF. Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal antiinflammatory drugs. Lancet. 1991;337:520.CrossRefGoogle Scholar
  22. 22.
    Kessler WF, Shires GT, Fahey TJ. Surgical complications of non-steroidal anti-inflammatory drug-induced small bowel ulceration. J Am Coll Surg. 1997;185:250–4.PubMedGoogle Scholar
  23. 23.
    Laine L, Connors LG, Reicin A, Hawkey CJ, Burgos-Vargas R, Schnitzer TJ, et al. Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use. Gastroenterology. 2003;124:288–92.CrossRefGoogle Scholar
  24. 24.
    Langman MJS, Morgan L, Worrall A. Use of anti-inflammatory drugs by patients with small or large bowel perforation and haemorrhage. BMJ. 1985;290:347–9.CrossRefGoogle Scholar
  25. 25.
    Silverstein FE, Graham GY, Senior JR, Davies HW, Struthers BJ, Bittman R, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. Ann Intern Med. 1995;123:241–9.CrossRefGoogle Scholar
  26. 26.
    Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs. N Engl J Med. 1992;327:749–54.CrossRefGoogle Scholar
  27. 27.
    Chan FKL, Hung LCT, Suen BY, Wu JC, Lee KC, Leung VK, et al. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med. 2002;347:2104–10.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Ulster HospitalDundonaldUK
  2. 2.State Pathologist’s DepartmentInstitute of Forensic MedicineBelfastUK

Personalised recommendations